⌘K

Home/Filings/4/0001144204-12-037328

4//SEC Filing

Biggar Stephen R 4

Accession 0001144204-12-037328

CIK 0000911326other

View on SEC.gov Company Profile

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 4:14 PM ET

Size

5.2 KB

Accession

0001144204-12-037328

Insider Transaction Report

Form 4

Period: 2012-06-27

SYNAGEVA BIOPHARMA CORPGEVA

Biggar Stephen R

Director

Transactions

Award
Stock Option (Right to Buy)
2012-06-27+7,500→ 7,500 total
Exercise: $40.74Exp: 2022-06-27→ Common Stock (7,500 underlying)

Footnotes (1)

[F1]1/12 of the shares subject to this option vest and become exercisable on July 27, 2012 and monthly thereafter.

Documents

1 file

4
form451559_20120629041403-.xmlPrimary

Issuer

SYNAGEVA BIOPHARMA CORP

CIK 0000911326

Entity typeother

Related Parties

1

filerCIK 0001340380

Filing Metadata

Form type: 4
Filed: Jun 28, 8:00 PM ET
Accepted: Jun 29, 4:14 PM ET
Size: 5.2 KB

View on SEC.gov